Home › Epilepsy › Alabama › Birmingham
Epilepsy clinical trials in Birmingham, AL
7 studies for Epilepsy are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RecruitingObservational study
- UAB Epilepsy Center, Birmingham
Diagnosing Epilepsy To EffeCT Change
Recruiting
- UAB Epilepsy Center, Birmingham
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
RecruitingPhase 1/2
- University of Alabama at Birmingham, Birmingham
Stimulation-Induced Changes in Fronto-Limbic Network
Recruiting
- Epilepsy Monitoring Unit UAB Hospital, Birmingham
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- University of Alabama, Birmingham
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA19 studies
- Houston, TX16 studies
- New York City, NY13 studies
- Washington, DC12 studies
- Philadelphia, PA11 studies
- Cleveland, OH9 studies
- Phoenix, AZ9 studies
- Durham, NC8 studies
- Rochester, MN8 studies
- Mountain View, CA7 studies
- St. Louis, MO7 studies
- Miami, FL7 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.